Global Generic Active Pharmaceutical Ingredients Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Generic Active Pharmaceutical Ingredients Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Generic Active Pharmaceutical Ingredients by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Generic Active Pharmaceutical Ingredients by Country/Region, 2017, 2022 & 2028

2.2 Generic Active Pharmaceutical Ingredients Segment by Type

2.2.1 Monoclonal Antibodies

2.2.2 Hormones

2.2.3 Cytokines

2.2.4 Fusion Proteins

2.2.5 Therapeutic Enzymes

2.2.6 Vaccines

2.2.7 Blood Factors

2.3 Generic Active Pharmaceutical Ingredients Sales by Type

2.3.1 Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)

2.3.2 Global Generic Active Pharmaceutical Ingredients Revenue and Market Share by Type (2017-2022)

2.3.3 Global Generic Active Pharmaceutical Ingredients Sale Price by Type (2017-2022)

2.4 Generic Active Pharmaceutical Ingredients Segment by Application

2.4.1 Oncology

2.4.2 Diabetes

2.4.3 Cardiovascular Disease

2.4.4 CNS and Neurological Disorders

2.4.5 Endocrinology

2.4.6 Others

2.5 Generic Active Pharmaceutical Ingredients Sales by Application

2.5.1 Global Generic Active Pharmaceutical Ingredients Sale Market Share by Application (2017-2022)

2.5.2 Global Generic Active Pharmaceutical Ingredients Revenue and Market Share by Application (2017-2022)

2.5.3 Global Generic Active Pharmaceutical Ingredients Sale Price by Application (2017-2022)

3 Global Generic Active Pharmaceutical Ingredients by Company

3.1 Global Generic Active Pharmaceutical Ingredients Breakdown Data by Company

3.1.1 Global Generic Active Pharmaceutical Ingredients Annual Sales by Company (2020-2022)

3.1.2 Global Generic Active Pharmaceutical Ingredients Sales Market Share by Company (2020-2022)

3.2 Global Generic Active Pharmaceutical Ingredients Annual Revenue by Company (2020-2022)

3.2.1 Global Generic Active Pharmaceutical Ingredients Revenue by Company (2020-2022)

3.2.2 Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Company (2020-2022)

3.3 Global Generic Active Pharmaceutical Ingredients Sale Price by Company

3.4 Key Manufacturers Generic Active Pharmaceutical Ingredients Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Generic Active Pharmaceutical Ingredients Product Location Distribution

3.4.2 Players Generic Active Pharmaceutical Ingredients Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Generic Active Pharmaceutical Ingredients by Geographic Region

4.1 World Historic Generic Active Pharmaceutical Ingredients Market Size by Geographic Region (2017-2022)

4.1.1 Global Generic Active Pharmaceutical Ingredients Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Generic Active Pharmaceutical Ingredients Annual Revenue by Geographic Region

4.2 World Historic Generic Active Pharmaceutical Ingredients Market Size by Country/Region (2017-2022)

4.2.1 Global Generic Active Pharmaceutical Ingredients Annual Sales by Country/Region (2017-2022)

4.2.2 Global Generic Active Pharmaceutical Ingredients Annual Revenue by Country/Region

4.3 Americas Generic Active Pharmaceutical Ingredients Sales Growth

4.4 APAC Generic Active Pharmaceutical Ingredients Sales Growth

4.5 Europe Generic Active Pharmaceutical Ingredients Sales Growth

4.6 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Growth

5 Americas

5.1 Americas Generic Active Pharmaceutical Ingredients Sales by Country

5.1.1 Americas Generic Active Pharmaceutical Ingredients Sales by Country (2017-2022)

5.1.2 Americas Generic Active Pharmaceutical Ingredients Revenue by Country (2017-2022)

5.2 Americas Generic Active Pharmaceutical Ingredients Sales by Type

5.3 Americas Generic Active Pharmaceutical Ingredients Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Generic Active Pharmaceutical Ingredients Sales by Region

6.1.1 APAC Generic Active Pharmaceutical Ingredients Sales by Region (2017-2022)

6.1.2 APAC Generic Active Pharmaceutical Ingredients Revenue by Region (2017-2022)

6.2 APAC Generic Active Pharmaceutical Ingredients Sales by Type

6.3 APAC Generic Active Pharmaceutical Ingredients Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Generic Active Pharmaceutical Ingredients by Country

7.1.1 Europe Generic Active Pharmaceutical Ingredients Sales by Country (2017-2022)

7.1.2 Europe Generic Active Pharmaceutical Ingredients Revenue by Country (2017-2022)

7.2 Europe Generic Active Pharmaceutical Ingredients Sales by Type

7.3 Europe Generic Active Pharmaceutical Ingredients Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Generic Active Pharmaceutical Ingredients by Country

8.1.1 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Country (2017-2022)

8.1.2 Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue by Country (2017-2022)

8.2 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Type

8.3 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Generic Active Pharmaceutical Ingredients

10.3 Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients

10.4 Industry Chain Structure of Generic Active Pharmaceutical Ingredients

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Generic Active Pharmaceutical Ingredients Distributors

11.3 Generic Active Pharmaceutical Ingredients Customer

12 World Forecast Review for Generic Active Pharmaceutical Ingredients by Geographic Region

12.1 Global Generic Active Pharmaceutical Ingredients Market Size Forecast by Region

12.1.1 Global Generic Active Pharmaceutical Ingredients Forecast by Region (2023-2028)

12.1.2 Global Generic Active Pharmaceutical Ingredients Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Generic Active Pharmaceutical Ingredients Forecast by Type

12.7 Global Generic Active Pharmaceutical Ingredients Forecast by Application

13 Key Players Analysis

13.1 Pfizer, Inc. (U.S.)

13.1.1 Pfizer, Inc. (U.S.) Company Information

13.1.2 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product Offered

13.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer, Inc. (U.S.) Main Business Overview

13.1.5 Pfizer, Inc. (U.S.) Latest Developments

13.2 Novartis International AG (Switzerland)

13.2.1 Novartis International AG (Switzerland) Company Information

13.2.2 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Product Offered

13.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis International AG (Switzerland) Main Business Overview

13.2.5 Novartis International AG (Switzerland) Latest Developments

13.3 Sanofi (France)

13.3.1 Sanofi (France) Company Information

13.3.2 Sanofi (France) Generic Active Pharmaceutical Ingredients Product Offered

13.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi (France) Main Business Overview

13.3.5 Sanofi (France) Latest Developments

13.4 Boehringer Ingelheim (Germany)

13.4.1 Boehringer Ingelheim (Germany) Company Information

13.4.2 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Product Offered

13.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Boehringer Ingelheim (Germany) Main Business Overview

13.4.5 Boehringer Ingelheim (Germany) Latest Developments

13.5 Bristol-Myers Squibb (U.S.)

13.5.1 Bristol-Myers Squibb (U.S.) Company Information

13.5.2 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Product Offered

13.5.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bristol-Myers Squibb (U.S.) Main Business Overview

13.5.5 Bristol-Myers Squibb (U.S.) Latest Developments

13.6 Teva Pharmaceutical Industries Ltd. (Israel)

13.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Information

13.6.2 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Product Offered

13.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Teva Pharmaceutical Industries Ltd. (Israel) Main Business Overview

13.6.5 Teva Pharmaceutical Industries Ltd. (Israel) Latest Developments

13.7 Eli Lilly and Company (U.S.)

13.7.1 Eli Lilly and Company (U.S.) Company Information

13.7.2 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Product Offered

13.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Eli Lilly and Company (U.S.) Main Business Overview

13.7.5 Eli Lilly and Company (U.S.) Latest Developments

13.8 GlaxoSmithKline plc (U.K.)

13.8.1 GlaxoSmithKline plc (U.K.) Company Information

13.8.2 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Product Offered

13.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 GlaxoSmithKline plc (U.K.) Main Business Overview

13.8.5 GlaxoSmithKline plc (U.K.) Latest Developments

13.9 Merck & Co., Inc. (U.S.)

13.9.1 Merck & Co., Inc. (U.S.) Company Information

13.9.2 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product Offered

13.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Merck & Co., Inc. (U.S.) Main Business Overview

13.9.5 Merck & Co., Inc. (U.S.) Latest Developments

13.10 AbbVie Inc. (U.S.)

13.10.1 AbbVie Inc. (U.S.) Company Information

13.10.2 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product Offered

13.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 AbbVie Inc. (U.S.) Main Business Overview

13.10.5 AbbVie Inc. (U.S.) Latest Developments

14 Research Findings and Conclusion

Table 1. Generic Active Pharmaceutical Ingredients Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Generic Active Pharmaceutical Ingredients Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Monoclonal Antibodies

Table 4. Major Players of Hormones

Table 5. Major Players of Cytokines

Table 6. Major Players of Fusion Proteins

Table 7. Major Players of Therapeutic Enzymes

Table 8. Major Players of Vaccines

Table 9. Major Players of Blood Factors

Table 10. Global Generic Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 11. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)

Table 12. Global Generic Active Pharmaceutical Ingredients Revenue by Type (2017-2022) & ($ million)

Table 13. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2022)

Table 14. Global Generic Active Pharmaceutical Ingredients Sale Price by Type (2017-2022) & (USD/MT)

Table 15. Global Generic Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 16. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)

Table 17. Global Generic Active Pharmaceutical Ingredients Revenue by Application (2017-2022)

Table 18. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Application (2017-2022)

Table 19. Global Generic Active Pharmaceutical Ingredients Sale Price by Application (2017-2022) & (USD/MT)

Table 20. Global Generic Active Pharmaceutical Ingredients Sales by Company (2020-2022) & (K MT)

Table 21. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Company (2020-2022)

Table 22. Global Generic Active Pharmaceutical Ingredients Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Company (2020-2022)

Table 24. Global Generic Active Pharmaceutical Ingredients Sale Price by Company (2020-2022) & (USD/MT)

Table 25. Key Manufacturers Generic Active Pharmaceutical Ingredients Producing Area Distribution and Sales Area

Table 26. Players Generic Active Pharmaceutical Ingredients Products Offered

Table 27. Generic Active Pharmaceutical Ingredients Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Generic Active Pharmaceutical Ingredients Sales by Geographic Region (2017-2022) & (K MT)

Table 31. Global Generic Active Pharmaceutical Ingredients Sales Market Share Geographic Region (2017-2022)

Table 32. Global Generic Active Pharmaceutical Ingredients Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Generic Active Pharmaceutical Ingredients Sales by Country/Region (2017-2022) & (K MT)

Table 35. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Country/Region (2017-2022)

Table 36. Global Generic Active Pharmaceutical Ingredients Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Generic Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)

Table 39. Americas Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2017-2022)

Table 40. Americas Generic Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2017-2022)

Table 42. Americas Generic Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 43. Americas Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)

Table 44. Americas Generic Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 45. Americas Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)

Table 46. APAC Generic Active Pharmaceutical Ingredients Sales by Region (2017-2022) & (K MT)

Table 47. APAC Generic Active Pharmaceutical Ingredients Sales Market Share by Region (2017-2022)

Table 48. APAC Generic Active Pharmaceutical Ingredients Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Generic Active Pharmaceutical Ingredients Revenue Market Share by Region (2017-2022)

Table 50. APAC Generic Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 51. APAC Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)

Table 52. APAC Generic Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 53. APAC Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)

Table 54. Europe Generic Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)

Table 55. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2017-2022)

Table 56. Europe Generic Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2017-2022)

Table 58. Europe Generic Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 59. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)

Table 60. Europe Generic Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 61. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Country (2017-2022) & (K MT)

Table 63. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Type (2017-2022) & (K MT)

Table 67. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Application (2017-2022) & (K MT)

Table 69. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Generic Active Pharmaceutical Ingredients

Table 71. Key Market Challenges & Risks of Generic Active Pharmaceutical Ingredients

Table 72. Key Industry Trends of Generic Active Pharmaceutical Ingredients

Table 73. Generic Active Pharmaceutical Ingredients Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Generic Active Pharmaceutical Ingredients Distributors List

Table 76. Generic Active Pharmaceutical Ingredients Customer List

Table 77. Global Generic Active Pharmaceutical Ingredients Sales Forecast by Region (2023-2028) & (K MT)

Table 78. Global Generic Active Pharmaceutical Ingredients Sales Market Forecast by Region

Table 79. Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Generic Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Generic Active Pharmaceutical Ingredients Sales Forecast by Country (2023-2028) & (K MT)

Table 82. Americas Generic Active Pharmaceutical Ingredients Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Generic Active Pharmaceutical Ingredients Sales Forecast by Region (2023-2028) & (K MT)

Table 84. APAC Generic Active Pharmaceutical Ingredients Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Generic Active Pharmaceutical Ingredients Sales Forecast by Country (2023-2028) & (K MT)

Table 86. Europe Generic Active Pharmaceutical Ingredients Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Forecast by Country (2023-2028) & (K MT)

Table 88. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Generic Active Pharmaceutical Ingredients Sales Forecast by Type (2023-2028) & (K MT)

Table 90. Global Generic Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Generic Active Pharmaceutical Ingredients Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Generic Active Pharmaceutical Ingredients Sales Forecast by Application (2023-2028) & (K MT)

Table 94. Global Generic Active Pharmaceutical Ingredients Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Generic Active Pharmaceutical Ingredients Revenue Market Share Forecast by Application (2023-2028)

Table 97. Pfizer, Inc. (U.S.) Basic Information, Generic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors

Table 98. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product Offered

Table 99. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Pfizer, Inc. (U.S.) Main Business

Table 101. Pfizer, Inc. (U.S.) Latest Developments

Table 102. Novartis International AG (Switzerland) Basic Information, Generic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors

Table 103. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Product Offered

Table 104. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Novartis International AG (Switzerland) Main Business

Table 106. Novartis International AG (Switzerland) Latest Developments

Table 107. Sanofi (France) Basic Information, Generic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors

Table 108. Sanofi (France) Generic Active Pharmaceutical Ingredients Product Offered

Table 109. Sanofi (France) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Sanofi (France) Main Business

Table 111. Sanofi (France) Latest Developments

Table 112. Boehringer Ingelheim (Germany) Basic Information, Generic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors

Table 113. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Product Offered

Table 114. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. Boehringer Ingelheim (Germany) Main Business

Table 116. Boehringer Ingelheim (Germany) Latest Developments

Table 117. Bristol-Myers Squibb (U.S.) Basic Information, Generic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors

Table 118. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Product Offered

Table 119. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Bristol-Myers Squibb (U.S.) Main Business

Table 121. Bristol-Myers Squibb (U.S.) Latest Developments

Table 122. Teva Pharmaceutical Industries Ltd. (Israel) Basic Information, Generic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors

Table 123. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Product Offered

Table 124. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. Teva Pharmaceutical Industries Ltd. (Israel) Main Business

Table 126. Teva Pharmaceutical Industries Ltd. (Israel) Latest Developments

Table 127. Eli Lilly and Company (U.S.) Basic Information, Generic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors

Table 128. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Product Offered

Table 129. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. Eli Lilly and Company (U.S.) Main Business

Table 131. Eli Lilly and Company (U.S.) Latest Developments

Table 132. GlaxoSmithKline plc (U.K.) Basic Information, Generic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors

Table 133. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Product Offered

Table 134. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. GlaxoSmithKline plc (U.K.) Main Business

Table 136. GlaxoSmithKline plc (U.K.) Latest Developments

Table 137. Merck & Co., Inc. (U.S.) Basic Information, Generic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors

Table 138. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product Offered

Table 139. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. Merck & Co., Inc. (U.S.) Main Business

Table 141. Merck & Co., Inc. (U.S.) Latest Developments

Table 142. AbbVie Inc. (U.S.) Basic Information, Generic Active Pharmaceutical Ingredients Manufacturing Base, Sales Area and Its Competitors

Table 143. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product Offered

Table 144. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 145. AbbVie Inc. (U.S.) Main Business

Table 146. AbbVie Inc. (U.S.) Latest Developments

List of Figures

Figure 1. Picture of Generic Active Pharmaceutical Ingredients

Figure 2. Generic Active Pharmaceutical Ingredients Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Generic Active Pharmaceutical Ingredients Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Generic Active Pharmaceutical Ingredients Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Generic Active Pharmaceutical Ingredients Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Monoclonal Antibodies

Figure 10. Product Picture of Hormones

Figure 11. Product Picture of Cytokines

Figure 12. Product Picture of Fusion Proteins

Figure 13. Product Picture of Therapeutic Enzymes

Figure 14. Product Picture of Vaccines

Figure 15. Product Picture of Blood Factors

Figure 16. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type in 2021

Figure 17. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Type (2017-2022)

Figure 18. Generic Active Pharmaceutical Ingredients Consumed in Oncology

Figure 19. Global Generic Active Pharmaceutical Ingredients Market: Oncology (2017-2022) & (K MT)

Figure 20. Generic Active Pharmaceutical Ingredients Consumed in Diabetes

Figure 21. Global Generic Active Pharmaceutical Ingredients Market: Diabetes (2017-2022) & (K MT)

Figure 22. Generic Active Pharmaceutical Ingredients Consumed in Cardiovascular Disease

Figure 23. Global Generic Active Pharmaceutical Ingredients Market: Cardiovascular Disease (2017-2022) & (K MT)

Figure 24. Generic Active Pharmaceutical Ingredients Consumed in CNS and Neurological Disorders

Figure 25. Global Generic Active Pharmaceutical Ingredients Market: CNS and Neurological Disorders (2017-2022) & (K MT)

Figure 26. Generic Active Pharmaceutical Ingredients Consumed in Endocrinology

Figure 27. Global Generic Active Pharmaceutical Ingredients Market: Endocrinology (2017-2022) & (K MT)

Figure 28. Generic Active Pharmaceutical Ingredients Consumed in Others

Figure 29. Global Generic Active Pharmaceutical Ingredients Market: Others (2017-2022) & (K MT)

Figure 30. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2017-2022)

Figure 31. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Application in 2021

Figure 32. Generic Active Pharmaceutical Ingredients Revenue Market by Company in 2021 ($ Million)

Figure 33. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Company in 2021

Figure 34. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Geographic Region (2017-2022)

Figure 35. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Geographic Region in 2021

Figure 36. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Region (2017-2022)

Figure 37. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Country/Region in 2021

Figure 38. Americas Generic Active Pharmaceutical Ingredients Sales 2017-2022 (K MT)

Figure 39. Americas Generic Active Pharmaceutical Ingredients Revenue 2017-2022 ($ Millions)

Figure 40. APAC Generic Active Pharmaceutical Ingredients Sales 2017-2022 (K MT)

Figure 41. APAC Generic Active Pharmaceutical Ingredients Revenue 2017-2022 ($ Millions)

Figure 42. Europe Generic Active Pharmaceutical Ingredients Sales 2017-2022 (K MT)

Figure 43. Europe Generic Active Pharmaceutical Ingredients Revenue 2017-2022 ($ Millions)

Figure 44. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales 2017-2022 (K MT)

Figure 45. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue 2017-2022 ($ Millions)

Figure 46. Americas Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2021

Figure 47. Americas Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2021

Figure 48. United States Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 49. Canada Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 50. Mexico Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 51. Brazil Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 52. APAC Generic Active Pharmaceutical Ingredients Sales Market Share by Region in 2021

Figure 53. APAC Generic Active Pharmaceutical Ingredients Revenue Market Share by Regions in 2021

Figure 54. China Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 55. Japan Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 56. South Korea Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 57. Southeast Asia Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 58. India Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 59. Australia Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 60. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2021

Figure 61. Europe Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2021

Figure 62. Germany Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 63. France Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 64. UK Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 65. Italy Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 66. Russia Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 67. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Country in 2021

Figure 68. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue Market Share by Country in 2021

Figure 69. Egypt Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 70. South Africa Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 71. Israel Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 72. Turkey Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 73. GCC Country Generic Active Pharmaceutical Ingredients Revenue Growth 2017-2022 ($ Millions)

Figure 74. Manufacturing Cost Structure Analysis of Generic Active Pharmaceutical Ingredients in 2021

Figure 75. Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients

Figure 76. Industry Chain Structure of Generic Active Pharmaceutical Ingredients

Figure 77. Channels of Distribution

Figure 78. Distributors Profiles